TP53 and cancer: Another study showed that β-Lapachone, an anti-cancer drug, could restore SIRT1 (p < 0.05) and SIRT3 (p < 0.05) expression to the control level in 24-month-old mice, while β-Lapachone also decreased p53 expression (p < 0.05) [71].